LEADER 01532nas  2200493 a 450 
001 9910481984103321
005 20240413020422.0
011   $a1179-1934
035   $a(OCoLC)37663888
035   $a(CKB)954925612979
035   $a(CONSER)  2011250653
035   $a(MiFhGG)2PMK
035   $a(MiAaPQ)33311
035   $a(DE-599)ZDB2043806-0
035   $a(EXLCZ)99954925612979
100   $a19970922a19949999  sy 
101 0 $aeng
135   $aurmnu|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCNS drugs
210   $aMairangi Bay, Auckland, N.Z. $cAdis International$d1994-
300   $aRefereed/Peer-reviewed
311   $a1172-7047 
606   $aNeuropsychopharmacology$vPeriodicals
606   $aCentral Nervous System Diseases$xdrug therapy
606   $aMental Disorders$xdrug therapy
606   $aNervous System Diseases$xdrug therapy
606   $aPsychotropic Drugs$xtherapeutic use
606   $aNeuropsychopharmacologie$vPe?riodiques
608   $aPeriodical.
610 1 $aHumans$aNervous system$aDrug therapy
615  0$aNeuropsychopharmacology
615  2$aCentral Nervous System Diseases$xdrug therapy.
615  2$aMental Disorders$xdrug therapy.
615  2$aNervous System Diseases$xdrug therapy.
615  2$aPsychotropic Drugs$xtherapeutic use.
615  6$aNeuropsychopharmacologie
676   $a615.788
906   $aJOURNAL
912   $a9910481984103321
996   $aCNS drugs$92348780
997   $aUNINA